Mizuho lowered the firm’s price target on Tenet Healthcare to $77 from $94 and keeps a Buy rating on the shares. The analyst reduced estimates post the Q3 earnings report. However, the firm views this as a good quarter given the strong growth in surgical cases and labor cost improvement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on THC: